Oral Propranolol for Prevention of Threshold Retinopathy of Prematurity

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(3 sites)

Germany

University Hospital Tübingen, Tübingen, Baden-Wurttemberg

Switzerland

University Hospital Zurich, Zurich, Canton of Zurich

Turkey (Türkiye)

Ankara University School of Medicine Children's Hospital, Ankara, Ankara